REINFORCING EFFECTS OF EXTENDED INHALATION OF NITROUS-OXIDE IN HUMANS

被引:37
作者
DOHRN, CS
LICHTOR, JL
COALSON, DW
UITVLUGT, A
DEWIT, H
ZACNY, JP
机构
[1] UNIV CHICAGO, PRITZKER SCH MED,DEPT ANESTHESIA & CRIT CARE, BOX MC 4028,5841 S MARYLAND AVE, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, PRITZKER SCH MED, DEPT PSYCHOL, COMM BIOPSYCHOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, PRITZKER SCH MED, DEPT PSYCHIAT, CHICAGO, IL 60637 USA
关键词
NITROUS OXIDE; SUBJECTIVE EFFECTS; REINFORCING EFFECTS; GENDER DIFFERENCES; INDIVIDUAL DIFFERENCES; INHALANTS; HUMAN;
D O I
10.1016/0376-8716(93)90009-F
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The subjective, psychomotor and reinforcing effects of nitrous oxide at subanesthetic doses (30% and 40% in oxygen) were determined in normal healthy volunteers using a choice paradigm. Thirty percent nitrous oxide was chosen no more often than oxygen (41.6% choice rate), indicating that, for most of the subjects tested, extended inhalation of this nitrous oxide concentration was no more reinforcing than oxygen inhalation. Forty percent nitrous oxide was chosen significantly less often than oxygen (22% choice rate), indicating that, for most of the subjects tested, extended inhalation of this nitrous oxide concentration was less reinforcing than oxygen. Nitrous oxide produced robust subjective effects (e.g., increased ratings of 'high,' 'tingling,' and 'dizzy'). Subjects who chose nitrous oxide reported pleasant subjective effects and liked it, while those who chose placebo reported unpleasant subjective effects and disliked it. Both concentrations of nitrous oxide impaired psychomotor performance in all subjects. The lack of reinforcing effects noted in the present study, given nitrous oxide's known abuse potential, is
引用
收藏
页码:265 / 280
页数:16
相关论文
共 43 条
  • [21] Johanson C E, 1989, NIDA Res Monogr, V92, P171
  • [22] TIME COURSE OF MENTAL AND PSYCHOMOTOR EFFECTS OF 30-PERCENT NITROUS-OXIDE DURING INHALATION AND RECOVERY
    KORTTILA, K
    GHONEIM, MM
    JACOBS, L
    MEWALDT, SP
    PETERSEN, RC
    [J]. ANESTHESIOLOGY, 1981, 54 (03) : 220 - 226
  • [23] Kumar V., 1988, HUM PSYCHOPHARM CLIN, V3, P257, DOI [10.1002/hup.470030405, DOI 10.1002/HUP.470030405]
  • [24] Layzer R. B., 1985, NITROUS OXIDE N2O, VII, P249
  • [25] LAYZER RB, 1978, LANCET, V2, P1227
  • [26] EXPERIMENTAL NITROUS-OXIDE EXPOSURE AS A MODEL SYSTEM FOR EVALUATING NEURO-BEHAVIORAL TESTS
    MAHONEY, FC
    MOORE, PA
    BAKER, EL
    LETZ, R
    [J]. TOXICOLOGY, 1988, 49 (2-3) : 449 - 457
  • [27] MARSHALL BE, 1985, PHARMACOL BASIS THER, P276
  • [28] MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245
  • [29] MCCRACKEN SG, 1990, J CLIN PSYCHOPHARM, V10, P190
  • [30] Mello N K, 1989, NIDA Res Monogr, V92, P147